Cargando…

Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expression of Fas is associated with disease progression

The death receptor Fas (Apo1/CD95) and Fas ligand (FasL) system is recognised as a major pathway for the induction of apoptosis in vivo, and antiapoptosis via its blockade plays a critical role in carcinogenesis and progression in several malignancies. However, the function of Fas–FasL system in uro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamana, K, Bilim, V, Hara, N, Kasahara, T, Itoi, T, Maruyama, R, Nishiyama, T, Takahashi, K, Tomita, Y
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2005
Materias:	Translational Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361597/ https://www.ncbi.nlm.nih.gov/pubmed/16091761 http://dx.doi.org/10.1038/sj.bjc.6602732

Ejemplares similares

Absence of Bcl-2 and Fas/CD95/APO-1 predicts the response to immunotherapy in metastatic renal cell carcinoma
por: Maruyama, R, et al.
Publicado: (2006)

Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL
por: Rikhof, B, et al.
Publicado: (2008)

Fas/Fas ligand regulation mediates cell death in human Ewing's sarcoma cells treated with melatonin
por: García-Santos, G, et al.
Publicado: (2012)

Significance of serum-soluble CD95 (Fas/APO-1) on prognosis in renal cell cancer patients
por: Kimura, M, et al.
Publicado: (1999)

Signaling through the Death Receptor CD95 (APO-1/FAS)
por: Peter, Marcus E.
Publicado: (2001)

Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis
por: Bilim, V, et al.
Publicado: (2008)

Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation
por: Minas, V, et al.
Publicado: (2007)

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage
Publicado: (1995)

Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase
Publicado: (1994)

CD95/Fas promotes tumour growth
por: Chen, Lina, et al.
Publicado: (2010)

Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling
por: Han, Sheng, et al.
Publicado: (2017)

Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain
Publicado: (1996)

Tumour-induced apoptosis in human mesothelial cells: a mechanism of peritoneal invasion by Fas Ligand/Fas interaction
por: Heath, R M, et al.
Publicado: (2004)

Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma
por: Das, Satya N., et al.
Publicado: (2011)

Selective cleavage of nuclear autoantigens during CD95 (Fas/APO-1)- mediated T cell apoptosis
Publicado: (1996)

Ultraviolet Light Induces Apoptosis via Direct Activation of CD95 (Fas/APO-1) Independently of Its Ligand CD95L
por: Aragane, Yoshinori, et al.
Publicado: (1998)

Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils
Publicado: (1996)

CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases
por: Le Gallo, Matthieu, et al.
Publicado: (2017)

CD95/Fas ligand mRNA is toxic to cells
por: Putzbach, Will, et al.
Publicado: (2018)

p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
por: Müller, Martina, et al.
Publicado: (1998)

Differential expression of Fas receptors (CD95) and Fas ligands (CD95L) in HIV infected and exposed uninfected children in Cameroon versus unexposed children
por: Dambaya, Béatrice, et al.
Publicado: (2019)

CD95/Fas suppresses NF-κB activation through recruitment of KPC2 in a CD95L/FasL-independent mechanism
por: Guégan, Jean-Philippe, et al.
Publicado: (2021)

Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma
por: Bilim, V, et al.
Publicado: (2009)

CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway
Publicado: (1995)

Antiinflammatory Effects of CD95 Ligand (FasL)-induced Apoptosis
por: Gao, Yakun, et al.
Publicado: (1998)

Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas
por: Kelly, J D, et al.
Publicado: (2004)

Altered expression of membrane-bound and soluble CD95/Fas contributes to the resistance of fibrotic lung fibroblasts to FasL induced apoptosis
por: Bühling, Frank, et al.
Publicado: (2005)

Prognostic impact of apoptosis marker Fas (CD95) and its ligand (FasL) on bladder cancer in Egypt: study of the effect of schistosomiasis
por: Elmansy, HM, et al.
Publicado: (2012)

Transfer of Fas (CD95) protein from the cell surface to the surface of polystyrene beads coated with anti-Fas antibody clone CH-11
por: Sawai, H., et al.
Publicado: (2010)

Super-Resolution Imaging of Fas/CD95 Reorganization Induced by Membrane-Bound Fas Ligand Reveals Nanoscale Clustering Upstream of FADD Recruitment
por: Frazzette, Nicholas, et al.
Publicado: (2022)

The Central Executioner of Apoptosis: Multiple Connections between Protease Activation and Mitochondria in Fas/APO-1/CD95- and Ceramide-induced Apoptosis
por: Susin, Santos A., et al.
Publicado: (1997)

Asymmetric dimethylarginine attenuates serum starvation-induced apoptosis via suppression of the Fas (APO-1/CD95)/JNK (SAPK) pathway
por: Li, H, et al.
Publicado: (2013)

The Peripheral Deletion of Autoreactive CD8(+) T Cells Induced by Cross-presentation of Self-antigens Involves Signaling through CD95 (Fas, Apo-1)
por: Kurts, Christian, et al.
Publicado: (1998)

Levels of soluble Fas/APO-1 in patients with Behçet's disease.
por: Hamzaoui, K, et al.
Publicado: (1998)

A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice
Publicado: (1996)

Fas/CD95 Deficiency in Apc(Min/+) Mice Increases Intestinal Tumor Burden
por: Guillen-Ahlers, Hector, et al.
Publicado: (2010)

Deficient activation of CD95 (APO-1/ Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma
por: Ramp, U, et al.
Publicado: (2000)

Fas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction
por: Cruz, Anthony C., et al.
Publicado: (2016)

Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients
por: Itoi, T, et al.
Publicado: (2004)

The extracellular domains of FasL and Fas are sufficient for the formation of supramolecular FasL-Fas clusters of high stability
por: Henkler, Frank, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_k8s581blvh7c4sbg3memu2otbp